Expert opinions on implementation of MDMA-assisted therapy in Europe: critical appraisal towards training, clinical practice, and regulation

• DOI: 10.1080/20008066.2024.2378651
• Publication Date: 2024-08-08T08:07:52Z
• Authors: Jerome Herpers; Natalie Maximets; Noah N. N. van Do...; Josjan Zijlmans; Eric Vermetten
• Keywords: MDMA; Critical appraisal; Clinical Practice

Introduction: The positive results of MDMA from Phase 2 and 3 clinical trials in MDMA-assisted therapy (MDMA-AT) for the treatment post-traumatic stress disorder (PTSD) call a critical evaluation its regulatory status within European mental healthcare system. This is driven by recent submission MDMA-AT FDA approval United States. Unless coordinated efforts landscape start, there may be potential divergences national strategies. Gaining insights researchers clinicians involved application useful guiding discussion factors implementation.